Efficacy and Safety of TC+AVASTIN Versus TC in Patients With Metastatic Nasopharyngeal Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Intrapleural Bevacizumab After Pleural Drainage in the Context of Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab
- Status
- COMPLETED
- Phase
- PHASE4
A Multicenter, Clinical Study of FOLFOXIRI With Bevacizumab As First-line Therapy in Patients With mCRC
- Status
- COMPLETED
- Phase
- PHASE2
Modufolin (Arfolitixorin) in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Laser vs Bevacizumab Injection Alone in Treatment of Diabetic Macular Edema
- Status
- WITHDRAWN
- Phase
- PHASE2/PHASE3
Bevacizumab-containing Regimen for Metastatic Colorectal Cancer Failed to Cytotoxic Treatment
- Status
- UNKNOWN
- Phase
- PHASE2
Dose Escalation of Cisplatin Hyperthermic Intraperitoneal Chemotherapy After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
dMR During First Line Treatment of Non Squamous Lung Cancer: Time Course and Prognostic and Predictive Impact.
- Status
- UNKNOWN
- Phase
- NA
Bevacizumab Against Recurrent Retinal Detachment
- Status
- COMPLETED
- Phase
- PHASE2
CRLX101(NLG207) in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC)
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel Plus Bevacizumab for Elderly Patients With Stage IV NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain Metastases
- Status
- TERMINATED
- Phase
- PHASE3
Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study Comparing the Efficacy and Safety of Vanucizumab and FOLFOX With Bevacizumab and FOLFOX in Participants With Untreated Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety Study of Bevacizumab Plus Chemotherapy in EGFR-TKI Resistant Non-Squamous Non-Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2